Sort   by:  
 Page size 
UnknownClinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment.
Not available
S-EPMC11503049 | biostudies-literature
UnknownAssociation of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort study.
Not available
S-EPMC11485411 | biostudies-literature
UnknownSeverity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
Not available
S-EPMC7712850 | biostudies-literature
UnknownDiabetes Mellitus and Cognition: Pathway Analysis in the MEMENTO Cohort.
Not available
S-EPMC8397583 | biostudies-literature
UnknownCognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers.
Not available
S-EPMC11971688 | biostudies-literature
UnknownCOVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Not available
S-EPMC7993930 | biostudies-literature
UnknownCOVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
Not available
S-EPMC9091487 | biostudies-literature
UnknownEffect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial.
Not available
S-EPMC7825875 | biostudies-literature
UnknownSarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.
Not available
S-EPMC8598187 | biostudies-literature
UnknownEffect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
Not available
S-EPMC7577198 | biostudies-literature
Sort   by:  
 Page size